BIO-Europe Spring Digital 2022-16th Annual Partnering Conference

被引：0
|
作者：
Cruces, Elisabet [1 ]
机构：
[1] Clarivate, Barcelona, Spain
来源：
DRUGS OF THE FUTURE | 2022年 / 47卷 / 05期
关键词：
Drug R&D; Partnering; Drug pipeline; Outlicensing;
D O I：
10.1358/dof.2022.47.5.3433515
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The 2022 BIO-Europe Spring conference, conducted as a 4-day partnering digital event, was joined by 2,145 attendees and 1,328 companies, including big pharma, midsize and start-up/early-stage companies and academic institutions. The participants had the opportunity to take part in panel discussions, fireside chats, live networking events and company presentations, encompassing the latest trends in life sciences markets, including the impact of digital health technologies in healthcare and current and future challenges in dealmaking.
引用
收藏
页码：399 / 405
页数：7
相关论文
共 50 条
12345